Anticoagulation Stewardship Series: Session 3

19th January 2022 19.15-20.45


Session 3: ‘CVDPREVENT: Understanding the New National Audit – The Pharmacist’s Role, Focus &

What will you learn from this meeting? CVDPREVENT is evolving. This new pharmacy element will launch across to
pharmacy professionals by the beginning 2022. This session will support your understanding of this new national audit and
prepare for implementation across all pharmacy sectors.

These events are sponsored by Bristol Myers Squibb/Pfizer

19:15 – 19:30 Joining & Registration
19:30 – 19:40 Welcome, Introduction and Learnings – Mr Raj R Patel, Pharmacist/Director of Operations, Consortium.Media
19:40 – 19:50 CVDPREVENT – What is it? How does it fit with the NHS Long Term Plan? – Dr Richard Brown, Chief Officer, Avon LPC
19:50 – 20:00 CVDPREVENT – Delivering Optimal Anticoagulation to Fulfil This Audit – Detection, Protection and Perfection: The Implications for each Pharmacy Sector – Miss Alison Freemantle, Professional Services Development Manager, Community Pharmacy
South Central
20:00 – 20:30 A Theoretical Interactive Case Study: Detecting NVAF in the Pharmacy setting. – Dr Michael Jackson, Lead Cardiovascular Pharmacist/Deputy Lead Clinical Services Pharmacist, East Kent Hospitals University NHS Foundation Trust
20:30 – 20:40 Panel Q&A Session – All
20:40 – 20:45 Key Take Home Messages/ What’s Next in This Pharmacist Meeting Series? – Mr Raj R Patel, Pharmacist/Director of Operations
20:45 Meeting close

To book your place contact:,  07776 657042

For full details of the series click here.